Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 71205-726

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 71205-726). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph showing lung function (liters) over time (hours after dosing) for Albuterol, Ipratropium, and Ipratropium Bromide and Albuterol Sulfate Inhalation Solution. The graph depicts changes in lung volume up to 8 hours post-dose for each treatment, with distinct markers for each drug or combination.*

FDA Label Image

Figure2 (Figure2)

An instructional black-and-white illustration showing a person inserting a dropper tip into an inhaler device while holding the inhaler with the other hand, demonstrating the step to add medication solution into the inhaler chamber for respiratory inhalation use.*

FDA Label Image

Figure3 (Figure3)

An instructional illustration demonstrating the attachment of a small cylindrical component to a respiratory inhalation device, showing two hands holding the parts separately just before connecting them.*

FDA Label Image

Figure4 (Figure4)

Instructional diagram showing a person using a respiratory inhalation device. The left panel depicts the person inhaling directly through the mouthpiece, while the right panel shows the use of a facemask attached to the inhalation device. Both images emphasize the hand positioning on the device during use.*

FDA Label Image

71205-726-15 (Snowbox 1)

Label for Ipratropium Bromide and Albuterol Sulfate 0.5 mg / 3 mg per 3 mL inhalation solution, 15 mL total (five 3 mL unit-dose vials) by Proficient Rx LP. The label states each vial contains 0.5 mg ipratropium bromide USP and 3 mg albuterol sulfate USP, for oral inhalation only. Manufactured by Sun Pharmaceutical Medicare Limited, India.*

FDA Label Image

Structure1 (Structure1)

Chemical structure diagram of Albuterol Sulfate as part of the Ipratropium Bromide and Albuterol Sulfate combination product. The structure shows a benzene ring with attached hydroxyl groups and side chains relevant to the albuterol molecule.*

FDA Label Image

Structure2 (Structure2)

Chemical structure of Ipratropium Bromide, showing its molecular arrangement along with a bromide hydrate (Br·H2O) notation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.